Education
About Us
Working with TipRanks
Follow Us
Tomer Kariv Insider Profile
4 Followers
Tomer Kariv, Director at Eloxx Pharmaceuticals, holds 4.64M shares in Keros Therapeutics (Ticker: KROS), holds 7.80M shares in Eloxx Pharmaceuticals (Ticker: ELOX), holds 1.13M shares in 89bio (Ticker: ETNB).
Profitable Transactions
4 out of 8 Profitable Transactions
Average Return
+11.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Tomer Kariv holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 13, 2020 - Apr 13, 2021
Return:+175.70%
The most profitable trade made by Tomer Kariv
Tomer Kariv's Trading History
Eloxx Pharmaceuticals
May 17, 2021
Director
Informative Buy
8.00M
$5.85M
Logicbio Therapeutics
Oct 25, 2018
―
Uninformative Buy
―
$3.70M
89bio
Nov 13, 2019
Director, Ten Percent Owner
Uninformative Buy
―
$16.97M
VBI Vaccines
―
―
―
―
Keros Therapeutics
Jun 06, 2025
Director, Ten Percent Owner
Uninformative Buy
―
$74.38M
List of latest transactions for each holding click on a transaction to see Tomer Kariv's performance on stock
You May Also Like
Tomer Kariv insider profile FAQ
What is the percentage of profitable transactions made by Tomer Kariv?
The percentage of profitable transactions made by Tomer Kariv is 50%.
What is the average return per transaction made by Tomer Kariv?
The average return per transaction made by Tomer Kariv is 11.20%.
What stocks does Tomer Kariv hold?
Tomer Kariv holds: ELOX, ~LOGC, ETNB, VBIVQ, KROS stocks.
What was Tomer Kariv’s latest transaction?
Tomer Kariv latest transaction was an Uninformative Buy of ―.
What was Tomer Kariv's most profitable transaction?
Tomer Kariv’s most profitable transaction was an Informative Buy of KROS stock on April 13, 2020. The return on the trade was 175.70%.
What is Tomer Kariv's role in Eloxx Pharmaceuticals?
Tomer Kariv's role in Eloxx Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.